JOHN W. HUEMOELLER II - 10 Dec 2020 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Executive Officer, Director
Signature
/s/ John W. Huemoeller II
Issuer symbol
AXIM
Transactions as of
10 Dec 2020
Net transactions value
$0
Form type
4
Filing time
23 Sep 2022, 16:16:05 UTC
Previous filing
23 Sep 2022
Next filing
23 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Option Award $0 +3,000,000 +150% $0.000000 5,000,000 10 Dec 2020 Common Stock 3,000,000 $0.4200 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.